ShallowHRD: detection of homologous recombination deficiency from shallow whole genome sequencing.
Level V
Where this comes from
- Record sourced from PubMed, PMID 32315385.
- Also identified by DOI 10.1093/bioinformatics/btaa261 and PMC identifier 7320600.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We introduce shallowHRD, a software tool to evaluate tumor homologous recombination deficiency (HRD) based on whole genome sequencing (WGS) at low coverage (shallow WGS or sWGS; ∼1X coverage). The tool, based on mining copy number alterations profile, implements a fast and straightforward procedure that shows 87.5% sensitivity and 90.5% specificity for HRD detection. shallowHRD could be instrumental in predicting response to poly(ADP-ribose) polymerase inhibitors, to which HRD tumors are selectively sensitive. shallowHRD displays efficiency comparable to most state-of-art approaches, is cost-effective, generates low-storable outputs and is also suitable for fixed-formalin paraffin embedded tissues. shallowHRD R script and documentation are available at https://github.com/aeeckhou/shallowHRD. Supplementary data are available at Bioinformatics online.
Medical subject headings
- DNA Copy Number Variations
- Neoplasms